ABVC BioPharma Announces Fiscal Year 2022 Financial and Operational Results

April 2, 2023

https://www.globenewswire.com/news-release/2023/03/31/2639094/0/en/ABVC-BioPharma-Announces-Fiscal-Year-2022-Financial-and-Operational-Results.html

FREMONT, CA, March 31, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (Nasdaq:ABVC), a biotechnology company specializing in botanically based solutions that seeks to deliver high efficacy and low toxicity to improve health outcomes, today announced its financial and operating results for the fiscal year ended December 31, 2022.

Read more at globenewswire.com

Related news for (ABVC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.